Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention—prospective, single-center, randomized, parallel-group study

Abstract Background The data on bosentan were lacking for the treatment of exercise-induced elevation of pulmonary artery pressure (eePAP) or less severe PH in COPD. This study was conducted to investigate long-term efficacy and safety of bosentan for the treatment of eePAP or less severe PH in COPD...

Description complète

Détails bibliographiques

Auteurs principaux:	Takeru Kashiwada, Yosuke Tanaka, Toru Tanaka, Tetsuya Okano, Yoshinobu Saito, Masahiro Seike, Mitsunori Hino, Hiroshi Kimura, Akihiko Gemma
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-02-01
Collection:	BMC Pulmonary Medicine
Sujets:	Pulmonary hypertension COPD Right heart catheterization Echocardiography Endothelin receptor antagonists
Accès en ligne:	https://doi.org/10.1186/s12890-024-02895-0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!